| Dr Hercules Panayiotou, MD | |
|
1700 Springhill Ave, Suite 100, Mobile, AL 36604-1407 | |
| (251) 435-1200 | |
| (251) 435-6357 |
| Full Name | Dr Hercules Panayiotou |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 46 Years |
| Location | 1700 Springhill Ave, Mobile, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609822162 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 15500 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mobile Infirmary Medical Center | Mobile, AL | Hospital |
| North Baldwin Infirmary | Bay minette, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Imc-diagnostic And Medical Clinic Llc | 2860399623 | 135 |
News Archive
Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their stroke risk and comorbidities.
In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.
The Penn State College of Medicine's Department of Public Health Sciences has received a grant of about $54 million over seven years to act as the data coordinating center for the National Heart Lung and Blood Institute's AsthmaNet. This grant is one of the largest in the college's history. AsthmaNet is a research collaboration of multiple clinical centers across the nation that conducts clinical trials to address new treatments and asthma management.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
› Verified 7 days ago
| Entity Name | Imc-diagnostic And Medical Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447201066 PECOS PAC ID: 2860399623 Enrollment ID: O20031218000577 |
News Archive
Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their stroke risk and comorbidities.
In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.
The Penn State College of Medicine's Department of Public Health Sciences has received a grant of about $54 million over seven years to act as the data coordinating center for the National Heart Lung and Blood Institute's AsthmaNet. This grant is one of the largest in the college's history. AsthmaNet is a research collaboration of multiple clinical centers across the nation that conducts clinical trials to address new treatments and asthma management.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
› Verified 7 days ago
| Entity Name | University Of South Alabama Health Services Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962455881 PECOS PAC ID: 8426957952 Enrollment ID: O20040105000373 |
News Archive
Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their stroke risk and comorbidities.
In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.
The Penn State College of Medicine's Department of Public Health Sciences has received a grant of about $54 million over seven years to act as the data coordinating center for the National Heart Lung and Blood Institute's AsthmaNet. This grant is one of the largest in the college's history. AsthmaNet is a research collaboration of multiple clinical centers across the nation that conducts clinical trials to address new treatments and asthma management.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
› Verified 7 days ago
| Entity Name | University Of South Alabama |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992746838 PECOS PAC ID: 3072425149 Enrollment ID: O20040115000773 |
News Archive
Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their stroke risk and comorbidities.
In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.
The Penn State College of Medicine's Department of Public Health Sciences has received a grant of about $54 million over seven years to act as the data coordinating center for the National Heart Lung and Blood Institute's AsthmaNet. This grant is one of the largest in the college's history. AsthmaNet is a research collaboration of multiple clinical centers across the nation that conducts clinical trials to address new treatments and asthma management.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
› Verified 7 days ago
| Entity Name | Usa Health Physician Billing Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720645468 PECOS PAC ID: 9931436912 Enrollment ID: O20190814000827 |
News Archive
Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their stroke risk and comorbidities.
In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.
The Penn State College of Medicine's Department of Public Health Sciences has received a grant of about $54 million over seven years to act as the data coordinating center for the National Heart Lung and Blood Institute's AsthmaNet. This grant is one of the largest in the college's history. AsthmaNet is a research collaboration of multiple clinical centers across the nation that conducts clinical trials to address new treatments and asthma management.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hercules Panayiotou, MD 1700 Springhill Ave, Suite 100, Mobile, AL 36604-1407 Ph: (251) 435-1200 | Dr Hercules Panayiotou, MD 1700 Springhill Ave, Suite 100, Mobile, AL 36604-1407 Ph: (251) 435-1200 |
News Archive
Ensuring the protection of people's health and lives, especially in respirators and personal protective equipment (PPE) for use by health care personnel, has been one of the essential premises since the Artefactos community began to design and manufacture adaptations with which to face Covid-19.
General practitioners (GPs) undertreat women with atrial fibrillation (AF), according to research presented at ESC Congress 2013 today by Dr Pierre Sabouret from France. The analysis of more than 15,000 patients showed that women were undertreated with antithrombotic medications compared to men regardless of their stroke risk and comorbidities.
In March, in the early days of the coronavirus pandemic in Europe, a tweet from the French Health Minister, Olivier Verán, advised patients with COVID-19 not to take ibuprofen, an anti-inflammatory drug with analgesic and antipyretic properties.
The Penn State College of Medicine's Department of Public Health Sciences has received a grant of about $54 million over seven years to act as the data coordinating center for the National Heart Lung and Blood Institute's AsthmaNet. This grant is one of the largest in the college's history. AsthmaNet is a research collaboration of multiple clinical centers across the nation that conducts clinical trials to address new treatments and asthma management.
Cidara Therapeutics, Inc., a biotechnology company developing novel anti-infectives including immunotherapies, today announced that the first trial site has been activated for ReSTORE, a Phase 3 clinical trial evaluating the efficacy and safety of the company's lead antifungal, rezafungin, to treat candidemia and invasive candidiasis.
› Verified 7 days ago
Damian Joseph Collins, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 Spring Hill Ave, Suite 100, Mobile, AL 36604 Phone: 251-435-1200 Fax: 251-435-6357 | |
Lenore Landers Pierce, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-639-5775 Fax: 251-631-3581 | |
Peter Chestnutt Coats, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 6701 Airport Blvd, Suite A-101, Mobile, AL 36608 Phone: 251-633-8880 Fax: 251-634-4502 | |
Mr. Stephen Reeves Dill, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 6801 Airport Blvd # 11n, Mobile, AL 36608 Phone: 251-445-2412 Fax: 850-981-1878 | |
Dr. Dale Scott Kirby Jr., MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6701 Airport Blvd, Suite D-330, Mobile, AL 36608 Phone: 251-607-9797 Fax: 251-607-9761 | |
Sandeep Vidyadhar Bhadkamkar, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 6801 Airport Blvd, Mobile, AL 36608 Phone: 251-266-3580 Fax: 251-266-3581 | |
Reynaldo Rodriguez, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3601 Springhill Business Park, Mobile, AL 36608 Phone: 251-873-6192 Fax: 251-873-6193 |